Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)

Ipamorelin: Evidence Summary

Name: Ipamorelin Evidence Summary — Clinical Trial Data
Published: 2026-03-12

Evidence summary for Ipamorelin across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.

Back to Ipamorelin overview

Indication	Evidence Tier	Trial Count	Summary
GH secretion	Tier B	6	Well-characterized selective GH secretagogue in Phase II trials
Post-operative recovery	Tier B	2	Limited but positive trial data for GI recovery
Anti-aging	Tier D	0	Theoretical based on GH optimization, no direct evidence